RBPWorld - a comprehensive database of RNA Binding Proteins

Drugs target to TUBB4B

Drug name	Drug type	Disease/phenotype	Mechanism of action(MoA)	Phase	Status	Source
VINCRISTINE SULFATE	Small molecule	lymphoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	lymphoma	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	sarcoma	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	sarcoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	esophageal carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	inflammatory breast carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	ovarian mucinous cystadenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	head and neck carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast cancer	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
SOFITUZUMAB VEDOTIN	Antibody	ovarian cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	prostate cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	classic Hodgkin lymphoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	follicular lymphoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	post-transplant lymphoproliferative disease	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	metastatic prostate cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	neoplasm	Tubulin inhibitor	4.0	-	ATC
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	neoplasm	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	melanoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	ovarian carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	medulloblastoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	Central Nervous System Neoplasm	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Thymic Carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Uterine Carcinosarcoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINFLUNINE	Small molecule	penile neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	gastroesophageal junction adenocarcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	lung cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	endometrial cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	COVID-19	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	gastric carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	Hodgkins lymphoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	multiple myeloma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINFLUNINE	Small molecule	urogenital neoplasm	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	paranasal sinus neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	neuropathy	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	upper aerodigestive tract neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	malignant peritoneal mesothelioma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	2.0	Suspended	ClinicalTrials
VINCRISTINE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic adenocarcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	neuroendocrine carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	kidney cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	ovarian clear cell cystadenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	breast cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	follicular lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	multiple myeloma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	adult acute lymphoblastic leukemia	Tubulin inhibitor	4.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINCRISTINE	Small molecule	retinoblastoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	retinoblastoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINORELBINE	Small molecule	classic Hodgkin lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	follicular lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	astrocytoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	lymphoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	sarcoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
COLCHICINE	Small molecule	coronary artery disease	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
LADIRATUZUMAB VEDOTIN	Antibody	breast neoplasm	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	stomach neoplasm	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	drug-induced liver injury	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	triple-negative breast cancer	Tubulin inhibitor	2.0	Suspended	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	1.0	Suspended	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
TISOTUMAB VEDOTIN	Antibody	cervical cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	gastroesophageal junction adenocarcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	Ewing sarcoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINBLASTINE	Small molecule	neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
TUSAMITAMAB RAVTANSINE	Antibody	neoplasm	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
SOBLIDOTIN	Small molecule	sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	sarcoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	AIDS	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	cervical carcinoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	hypopharyngeal carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	anaplastic large cell lymphoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	4.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	Ovarian Carcinosarcoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINCRISTINE	Small molecule	Mantle cell lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	soft tissue sarcoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	lymphoblastic lymphoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
GLEMBATUMUMAB VEDOTIN	Antibody	breast cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	lung cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	squamous cell carcinoma of penis	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	metastatic malignant neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	gastric carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	Hodgkins lymphoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	embryonal rhabdomyosarcoma	Tubulin inhibitor	3.0	Suspended	ClinicalTrials
PACLITAXEL	Small molecule	leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	anemia (phenotype)	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
COLCHICINE	Small molecule	cholangiocarcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	bladder transitional cell carcinoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	toxicity	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic adenocarcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic adenocarcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
ERIBULIN	Small molecule	inflammatory breast carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
CABAZITAXEL	Small molecule	gastric cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	peritoneum cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	urethra cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Burkitts lymphoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	embryonal rhabdomyosarcoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINFLUNINE	Small molecule	neoplasm	Tubulin inhibitor	4.0	-	ATC
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINBLASTINE	Small molecule	melanoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	melanoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	nodular sclerosis Hodgkin lymphoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Anal Squamous Cell Carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	endometrial carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
FOSBRETABULIN	Small molecule	neuroendocrine neoplasm	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	endometrial adenosquamous carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	uterine leiomyosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	cervical cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
VINORELBINE	Small molecule	breast cancer	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINORELBINE	Small molecule	prostate cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	lung cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
CABAZITAXEL	Small molecule	metastatic prostate cancer	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	oral squamous cell carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	diffuse large B-cell lymphoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
INDUSATUMAB VEDOTIN	Antibody	gastric adenocarcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	lung adenocarcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
ERIBULIN	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	HIV infection	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
VINCRISTINE	Small molecule	lymphoid leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	childhood T acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
CABAZITAXEL	Small molecule	gastric cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	gastric cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	urinary bladder cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	peritoneum cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	cervical cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINORELBINE	Small molecule	breast cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
CABAZITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	lung cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
EPOTHILONE D	Small molecule	lung cancer	Tubulin stabiliser	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	T-cell acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
COLCHICINE	Small molecule	atrial fibrillation	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	breast adenocarcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	breast adenocarcinoma	Tubulin inhibitor	3.0	Suspended	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
ANG1005	Protein	glioblastoma multiforme	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	lymphoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	urogenital neoplasm	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Endometrial Serous Adenocarcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Genital neoplasm, female	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	childhood B acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	childhood T acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	lymphoblastic lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	4.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	breast ductal carcinoma in situ	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	neoplasm	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINCRISTINE	Small molecule	sarcoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	ovarian neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	endometrial neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	gout	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	pancreatic adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Richter syndrome	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	gastroesophageal junction adenocarcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	adult acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	breast cancer	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
GLEMBATUMUMAB VEDOTIN	Antibody	breast cancer	Tubulin inhibitor	0.5	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
ERIBULIN	Small molecule	breast carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	lymphoma	Tubulin inhibitor	4.0	Not yet recruiting	ClinicalTrials
VINCRISTINE	Small molecule	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	sarcoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	multiple myeloma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic ductal adenocarcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	anaplastic large cell lymphoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	Thymoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	urinary bladder cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	kidney cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
ERIBULIN	Small molecule	breast cancer	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
CABAZITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
ERIBULIN	Small molecule	epithelioid hemangioendothelioma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
COLCHICINE	Small molecule	COVID-19	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
CABAZITAXEL	Small molecule	metastatic prostate cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	metastatic prostate cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOLASTATIN-10	Small molecule	myelodysplastic syndrome	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	adenosquamous lung carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	embryonal rhabdomyosarcoma	Tubulin inhibitor	3.0	Suspended	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	leukemia	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
ERIBULIN	Small molecule	neoplasm	Tubulin inhibitor	4.0	-	ATC
ABT-751	Small molecule	neuroblastoma	Tubulin beta inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	laryngeal neoplasm	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	stomach neoplasm	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	angiosarcoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINBLASTINE	Small molecule	testicular neoplasm	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	ovarian mucinous cystadenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	lymphoblastic lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	thyroid cancer	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	urethra cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	4.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	lung cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	lung neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	nasal cavity and paranasal sinus carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	alveolar rhabdomyosarcoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINORELBINE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	non-Hodgkins lymphoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Malignant Ovarian Brenner Tumor	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	childhood B acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	uterine leiomyosarcoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	lymphoblastic lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	penile cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	biliary tract cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	urethra cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINORELBINE	Small molecule	breast cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
BELANTAMAB MAFODOTIN	Antibody	AL amyloidosis	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	T-cell acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	osteosarcoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	anaplastic large cell lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	non-small cell lung carcinoma	Tubulin stabiliser	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	uterine neoplasm	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	carcinoid tumor	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	bladder transitional cell carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
LORVOTUZUMAB MERTANSINE	Antibody	Pleuropulmonary blastoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	urinary bladder cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	nasal cavity carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	Wilms tumor	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
LAROTAXEL	Small molecule	breast cancer	Tubulin stabiliser	1.0	Completed	ClinicalTrials
LAROTAXEL	Small molecule	breast cancer	Tubulin stabiliser	2.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	breast cancer	Tubulin inhibitor	4.0	Recruiting	ClinicalTrials
ABT-751	Small molecule	prostate cancer	Tubulin beta inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	malignant colon neoplasm	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	bronchoalveolar adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	renal cell carcinoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
BELANTAMAB MAFODOTIN	Antibody	multiple myeloma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	urothelial carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	pancreatic adenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	4.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	endometrial cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
ERIBULIN	Small molecule	solitary fibrous tumor	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	chronic lymphocytic leukemia	Tubulin inhibitor	0.5	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	Ewing sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	carcinoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	leukemia	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOLASTATIN-10	Small molecule	sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
CABAZITAXEL	Small molecule	prostate carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
COLCHICINE	Small molecule	Behcet's syndrome	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	stomach neoplasm	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
IXABEPILONE	Small molecule	endometrium adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	urinary bladder cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	neutropenia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	central nervous system germ cell tumor	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	gastroesophageal junction adenocarcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINORELBINE	Small molecule	breast cancer	Tubulin inhibitor	4.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	nasal cavity and paranasal sinus squamous cell carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	4.0	-	DailyMed
COLCHICINE	Small molecule	coronary artery disease	Tubulin inhibitor	4.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
COLCHICINE	Small molecule	heart disease	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	stomach neoplasm	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
COLCHICINE	Small molecule	acute coronary syndrome	Tubulin inhibitor	4.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	mediastinal cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	urothelial carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	metastasis	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	kidney cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	adult acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	high grade B-cell lymphoma	Tubulin inhibitor	2.0	Suspended	ClinicalTrials
VINORELBINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOLASTATIN-10	Small molecule	leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	lung adenocarcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
IXABEPILONE	Small molecule	neoplasm	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
LORVOTUZUMAB MERTANSINE	Antibody	malignant peripheral nerve sheath tumor	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	4.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	esophageal carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	medulloblastoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	peripheral neuropathy	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	lymphoid leukemia	Tubulin inhibitor	4.0	Completed	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	male breast carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	Ovarian Carcinosarcoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	uterine cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	salivary gland cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	4.0	-	DailyMed
DOCETAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	lung cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	Hodgkins lymphoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	metastatic prostate cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	acute myeloid leukemia	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
CABAZITAXEL	Small molecule	glioblastoma multiforme	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINORELBINE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	lung disease	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINORELBINE	Small molecule	breast neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	stomach neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	angiosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	triple-negative breast cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	Central Nervous System Neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Primary Peritoneal Serous Adenocarcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	Sezary's disease	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	adult B acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
ENFORTUMAB VEDOTIN	Antibody	urinary bladder cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	salivary gland cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
CABAZITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	gastrointestinal stromal tumor	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	nasal cavity and paranasal sinus squamous cell carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Hereditary breast and ovarian cancer syndrome	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
LAROTAXEL	Small molecule	pancreatic neoplasm	Tubulin stabiliser	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	urogenital neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	testicular carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	Endometrial Serous Adenocarcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINBLASTINE	Small molecule	urinary bladder cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ENFORTUMAB VEDOTIN	Antibody	infiltrating bladder urothelial carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	gastrointestinal stromal tumor	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	endometrial cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
COLCHICINE	Small molecule	COVID-19	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	alveolar rhabdomyosarcoma	Tubulin inhibitor	3.0	Suspended	ClinicalTrials
PACLITAXEL	Small molecule	carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	cutaneous melanoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	leukemia	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINBLASTINE	Small molecule	lymphoid neoplasm	Tubulin inhibitor	4.0	-	DailyMed
DOCETAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	cholangiocarcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	bladder transitional cell carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
FOSBRETABULIN	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
FOSBRETABULIN	Small molecule	neuroendocrine neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	colorectal carcinoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
PLINABULIN	Small molecule	neutropenia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	peritoneum cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINBLASTINE	Small molecule	urinary bladder carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	4.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	lung cancer	Tubulin stabiliser	3.0	Terminated	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	high grade B-cell lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	4.0	-	DailyMed
PACLITAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	neuroblastoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
GLEMBATUMUMAB VEDOTIN	Antibody	melanoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
ARX-788	Unknown	breast neoplasm	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINORELBINE	Small molecule	breast neoplasm	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
VINCRISTINE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	gastric cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINORELBINE	Small molecule	cervical cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	biliary tract cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
IXABEPILONE	Small molecule	endometrial cancer	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
VINBLASTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	metastatic prostate cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	4.0	Recruiting	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	diffuse large B-cell lymphoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	germ cell tumor	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	melanoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	non-Hodgkins lymphoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	mesenchymoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINFLUNINE	Small molecule	urinary bladder cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	urinary bladder carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
ABT-751	Small molecule	breast cancer	Tubulin beta inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	chronic lymphocytic leukemia	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
VINBLASTINE	Small molecule	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	atrial fibrillation	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	cutaneous melanoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINORELBINE	Small molecule	cutaneous melanoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	lymphoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	lymphoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
CABAZITAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	4.0	Completed	ClinicalTrials
CABAZITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	brain neoplasm	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	brain neoplasm	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	colorectal cancer	Tubulin stabiliser	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	verrucous carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	liver cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	uterine cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	urinary bladder carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
CABAZITAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	follicular lymphoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	malignant glioma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	diffuse scleroderma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	Kaposi's sarcoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	squamous cell carcinoma	Tubulin stabiliser	1.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	lung carcinoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	ovarian carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic ductal adenocarcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	0.5	Unknown status	ClinicalTrials
ERIBULIN	Small molecule	breast neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	cardiac arrhythmia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	testicular neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	mediastinal cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	ovarian clear cell adenocarcinoma	Tubulin stabiliser	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	ovarian serous cystadenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Ovarian Transitional Cell Carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	soft tissue sarcoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
ERIBULIN	Small molecule	Hereditary breast and ovarian cancer syndrome	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	B-cell acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	adenosquamous lung carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	leiomyosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
LORVOTUZUMAB MERTANSINE	Antibody	neuroblastoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic adenocarcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	cervical squamous cell carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	Uterine Carcinosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	peritoneal neoplasm	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	cervical cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	follicular lymphoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
ERIBULIN	Small molecule	breast adenocarcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINBLASTINE	Small molecule	lymphoma	Tubulin inhibitor	4.0	-	DailyMed
VINCRISTINE	Small molecule	lymphoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	psoriasis	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	esophageal carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	ovarian neoplasm	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	metastasis	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	ovarian clear cell adenocarcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
MIRVETUXIMAB SORAVTANSINE	Antibody	Endometrial Serous Adenocarcinoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	Fallopian Tube Carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	Hepatoblastoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	tonsil cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	vaginal cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	breast cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	metastatic malignant neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
ANG1005	Protein	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	melanoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	esophageal carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	hypopharyngeal carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	myelosuppression	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	tonsil cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	urinary bladder cancer	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	cervical cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	biliary tract cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
CABAZITAXEL	Small molecule	cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	follicular lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	oral squamous cell carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
ERIBULIN	Small molecule	breast carcinoma	Tubulin inhibitor	1.0	Suspended	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	diffuse large B-cell lymphoma	Tubulin inhibitor	4.0	-	DailyMed,FDA
VINCRISTINE SULFATE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	embryonal rhabdomyosarcoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PATUPILONE	Small molecule	neoplasm	Tubulin stabiliser	1.0	Completed	ClinicalTrials
LORVOTUZUMAB MERTANSINE	Antibody	multiple myeloma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	laryngeal neoplasm	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic neoplasm	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINORELBINE	Small molecule	breast neoplasm	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINORELBINE	Small molecule	diffuse intrinsic pontine glioma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINORELBINE	Small molecule	Central Nervous System Neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	proliferative vitreoretinopathy	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
EPOTHILONE D	Small molecule	colorectal carcinoma	Tubulin stabiliser	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	lymphoblastic lymphoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINBLASTINE	Small molecule	urinary bladder cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINFLUNINE	Small molecule	head and neck carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	uterine cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	cervical adenosarcoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	COVID-19	Tubulin inhibitor	2.0	Enrolling by invitation	ClinicalTrials
CABAZITAXEL	Small molecule	metastatic prostate cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	4.0	-	DailyMed
DOCETAXEL	Small molecule	small cell lung carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PATUPILONE	Small molecule	kidney neoplasm	Tubulin stabiliser	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	upper aerodigestive tract neoplasm	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	endometrium adenocarcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	Mantle cell lymphoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	colorectal carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	peritoneum cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	fallopian tube cancer	Tubulin stabiliser	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	urinary bladder carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	follicular lymphoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	breast adenocarcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOLASTATIN-10	Small molecule	leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	leukemia	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	lung adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	neuroblastoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	neuroblastoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	synovial sarcoma	Tubulin inhibitor	1.0	Suspended	ClinicalTrials
PACLITAXEL	Small molecule	uterine sarcoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
ARX-788	Unknown	breast neoplasm	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	pancreatic adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	Central Nervous System Neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	neutropenia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	cervical cancer	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
CABAZITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	lung cancer	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	classic Hodgkin lymphoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	renal pelvis/ureter urothelial carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	Ewing sarcoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	diabetic nephropathy	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	diffuse large B-cell lymphoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINORELBINE	Small molecule	embryonal rhabdomyosarcoma	Tubulin inhibitor	3.0	Suspended	ClinicalTrials
IXABEPILONE	Small molecule	leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	mesothelioma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	neuroblastoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	ovarian carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	cervical adenocarcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	cervical adenocarcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	brain neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	urogenital neoplasm	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	drug-induced liver injury	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	triple-negative breast cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
COLCHICINE	Small molecule	coronavirus infectious disease	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	inflammatory breast carcinoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	mycosis fungoides	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	soft tissue sarcoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	breast cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
CABAZITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	lung cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	primary peritoneal carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	COVID-19	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
ENFORTUMAB VEDOTIN	Antibody	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
VINORELBINE	Small molecule	multiple myeloma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	esophageal carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic neoplasm	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	testicular neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	urothelial carcinoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
VINCRISTINE	Small molecule	Central Nervous System Neoplasm	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
IXABEPILONE	Small molecule	Endometrial Clear Cell Adenocarcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	Lymphoma, AIDS-Related	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
CABAZITAXEL	Small molecule	colorectal carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	adult acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
CABAZITAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	breast cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
LIFASTUZUMAB VEDOTIN	Antibody	ovarian cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	metastatic prostate cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	oral squamous cell carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	leukemia	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINBLASTINE	Small molecule	neoplasm	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	hypopharyngeal carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
IXABEPILONE	Small molecule	tongue neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
LADIRATUZUMAB VEDOTIN	Antibody	angiosarcoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	Mantle cell lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	Cachexia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	cervical cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
TISOTUMAB VEDOTIN	Antibody	cervical cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	cancer	Tubulin inhibitor	1.0	Suspended	ClinicalTrials
DOCETAXEL	Small molecule	cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	post-transplant lymphoproliferative disease	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	B-cell acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	Hodgkins lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PATUPILONE	Small molecule	melanoma	Tubulin stabiliser	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	primitive neuroectodermal tumor	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	Sezary's disease	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	lung cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	lung cancer	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	Hereditary breast and ovarian cancer syndrome	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	oral squamous cell carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	breast adenocarcinoma	Tubulin inhibitor	3.0	Suspended	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	embryonal rhabdomyosarcoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
IXABEPILONE	Small molecule	breast neoplasm	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINBLASTINE	Small molecule	testicular neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	nodular sclerosis Hodgkin lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	triple-negative breast cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	acute coronary syndrome	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINFLUNINE	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	follicular lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell squamous lung carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	metastatic prostate cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	breast ductal carcinoma in situ	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
ENFORTUMAB VEDOTIN	Antibody	neoplasm	Tubulin inhibitor	4.0	-	ATC
SAGOPILONE	Small molecule	non-small cell lung carcinoma	Tubulin stabiliser	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	gliosarcoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Suspended	ClinicalTrials
PACLITAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
TISOTUMAB VEDOTIN	Antibody	ovarian cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	T-cell acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
IXABEPILONE	Small molecule	neoplasm	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	sarcoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	multiple myeloma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	metastatic melanoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	oral cavity cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	Ovarian Carcinosarcoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	urethra cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINFLUNINE	Small molecule	breast cancer	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
VINORELBINE	Small molecule	breast cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	classic Hodgkin lymphoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	metastatic malignant neoplasm	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	metastatic prostate cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	embryonal rhabdomyosarcoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	synovial sarcoma	Tubulin inhibitor	1.0	Suspended	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	cervical adenocarcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	medulloblastoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	cervical squamous cell carcinoma	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	inflammatory breast carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	neuroendocrine carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
TISOTUMAB VEDOTIN	Antibody	fallopian tube cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	salivary gland cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	allergic disease	Tubulin inhibitor	3.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	prostate cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	retinoblastoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	lung cancer	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	neoplasm of mature B-cells	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	neoplasm of mature B-cells	Tubulin inhibitor	1.0	Suspended	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	lung adenocarcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	lymphoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	lymphoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
PLINABULIN	Small molecule	small cell lung carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	pharynx cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	HER2 Positive Breast Carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	laryngeal carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	breast cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	prostate cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	alveolar rhabdomyosarcoma	Tubulin inhibitor	3.0	Suspended	ClinicalTrials
VINCRISTINE	Small molecule	Kaposi's sarcoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	lymphoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	lymphoma	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	neuroblastoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
BMS-275183	Small molecule	non-small cell lung carcinoma	Tubulin stabiliser	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	colorectal cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	bladder transitional cell carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	Mantle cell lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	adult T acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	peritoneum cancer	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	thyroid cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	cervical cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	ovarian clear cell cystadenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINFLUNINE	Small molecule	urinary bladder carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	breast cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
ERIBULIN	Small molecule	breast cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
CABAZITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	classic Hodgkin lymphoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	extragonadal germ cell tumor	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	primary brain neoplasm	Tubulin inhibitor	0.5	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	chronic lymphocytic leukemia	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	melanoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic ductal adenocarcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic ductal adenocarcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	rhabdomyosarcoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINORELBINE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	Transitional Cell Carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	peritoneal neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	Postpericardiotomy Syndrome	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	urinary bladder cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	childhood ependymoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
CABAZITAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
ERIBULIN	Small molecule	breast cancer	Tubulin inhibitor	4.0	-	DailyMed
OMBRABULIN	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VANDORTUZUMAB VEDOTIN	Antibody	prostate cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	peripheral primitive neuroectodermal tumor	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	endometrium neoplasm	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	metastatic carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	oropharyngeal carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	T-cell acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
COLCHICINE	Small molecule	diabetic nephropathy	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	neoplasm	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
VINFLUNINE	Small molecule	small cell lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	melanoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	ovarian carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PLINABULIN	Small molecule	multiple myeloma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
IXABEPILONE	Small molecule	pancreatic carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	gout	Tubulin inhibitor	4.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	urothelial carcinoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	cervical cancer	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	gastroesophageal junction adenocarcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	graft versus host disease	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	mixed phenotype acute leukemia	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	malignant tumor of neck	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	rhabdomyosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	endometrium adenocarcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINBLASTINE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	inflammatory breast carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	soft tissue sarcoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	lymphoblastic lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	cervical cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
LORVOTUZUMAB MERTANSINE	Antibody	Wilms tumor	Tubulin inhibitor	2.0	Completed	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
VINBLASTINE	Small molecule	prostate cancer	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
VINBLASTINE	Small molecule	extragonadal germ cell tumor	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	follicular lymphoma	Tubulin inhibitor	2.0	Suspended	ClinicalTrials
DOCETAXEL	Small molecule	renal pelvis/ureter urothelial carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	oropharynx squamous cell carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	T-cell acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Suspended	ClinicalTrials
FOSBRETABULIN	Small molecule	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	small cell lung carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	chronic myeloproliferative disorder	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Fallopian Tube Carcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Malignant Ovarian Brenner Tumor	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Primary Peritoneal Serous Adenocarcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Mantle cell lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	kidney cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	cervical cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	lung cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	extragonadal germ cell tumor	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	neuroblastoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	ovarian carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
COLCHICINE	Small molecule	cirrhosis of liver	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	stomach neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	stomach neoplasm	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	mast-cell leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic adenocarcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	neuroendocrine carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	intracranial hemorrhage	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	neoplasm	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic ductal adenocarcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	triple-negative breast cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	soft tissue sarcoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	childhood acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	childhood germ cell tumor	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
IXABEPILONE	Small molecule	urethra cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
TELISOTUZUMAB VEDOTIN	Antibody	cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast cancer	Tubulin inhibitor	4.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	gestational trophoblastic neoplasm	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	lung neoplasm	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	metastatic carcinoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	high grade B-cell lymphoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
COLCHICINE	Small molecule	atrial fibrillation	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINORELBINE	Small molecule	lymphoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	small cell lung carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINORELBINE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	paranasal sinus neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	endometrial neoplasm	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Malignant Pancreatic Neoplasm	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	mesenchymoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	childhood T acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	childhood acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
CROLIBULIN	Small molecule	thyroid cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	gastroesophageal junction adenocarcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
VINORELBINE	Small molecule	breast cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	primary peritoneal carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	renal pelvis/ureter urothelial carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	metastatic carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	metastatic malignant neoplasm	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	metastatic malignant neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PATUPILONE	Small molecule	metastatic malignant neoplasm	Tubulin stabiliser	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	4.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	angioimmunoblastic T-cell lymphoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	testicular neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	testicular neoplasm	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	urinary bladder cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	cervical cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	urethra cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	salivary gland cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
CABAZITAXEL	Small molecule	cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	classic Hodgkin lymphoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	endometrial cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	primary peritoneal carcinoma	Tubulin inhibitor	0.5	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	lung neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	embryonal rhabdomyosarcoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	leukemia	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
CABAZITAXEL	Small molecule	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
CABAZITAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
ENFORTUMAB VEDOTIN	Antibody	urogenital neoplasm	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	triple-negative breast cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	gastric cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	vaginal cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	neuroendocrine carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	kidney cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	cervical cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
FOSBRETABULIN	Small molecule	cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
CABAZITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
EPOTHILONE D	Small molecule	lung cancer	Tubulin stabiliser	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	follicular lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	renal pelvis/ureter urothelial carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	Burkitts lymphoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	carcinoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
CABAZITAXEL	Small molecule	central nervous system cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
FOSBRETABULIN	Small molecule	neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	multiple myeloma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
ABT-751	Small molecule	non-small cell lung carcinoma	Tubulin beta inhibitor	1.0	Terminated	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	breast neoplasm	Tubulin inhibitor	4.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	male breast carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	HER2 Positive Breast Carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Ovarian Transitional Cell Carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	thyroid cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
INDIBULIN	Small molecule	cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINORELBINE	Small molecule	breast cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	retinoblastoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	follicular lymphoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
CABAZITAXEL	Small molecule	metastatic prostate cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
IXABEPILONE	Small molecule	clear cell renal carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	neoplasm	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	ovarian serous adenocarcinoma	Tubulin stabiliser	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	anaplastic large cell lymphoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	Sinonasal Undifferentiated Carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PLINABULIN	Small molecule	neutropenia	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
ERIBULIN	Small molecule	urethra cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
VINORELBINE	Small molecule	lung cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINBLASTINE	Small molecule	renal pelvis/ureter urothelial carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	neoplasm of mature B-cells	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINBLASTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	colorectal adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	germ cell tumor	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	myocardial infarction	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	neoplasm	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
BELANTAMAB MAFODOTIN	Antibody	neoplasm	Tubulin inhibitor	4.0	-	ATC
PACLITAXEL	Small molecule	pancreatic ductal adenocarcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINORELBINE	Small molecule	anaplastic large cell lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	Mantle cell lymphoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	childhood B acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	gastric cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	head and neck carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	metastatic malignant neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	leukemia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	4.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	ovarian carcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	brain neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
LAROTAXEL	Small molecule	breast neoplasm	Tubulin stabiliser	2.0	Completed	ClinicalTrials
LADIRATUZUMAB VEDOTIN	Antibody	triple-negative breast cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic adenocarcinoma	Tubulin inhibitor	4.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	Mantle cell lymphoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	gastric cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	urinary bladder cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	penile cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	breast cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	endometrial cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	leukemia	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	sarcoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINORELBINE	Small molecule	breast neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Endometrial Serous Adenocarcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	vulva cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	cervical cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	ovarian clear cell cystadenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	extragonadal germ cell tumor	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	renal pelvis/ureter urothelial carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	acute myeloid leukemia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	neoplasm	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	osteosarcoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	sarcoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	0.5	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	melanoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
SAGOPILONE	Small molecule	ovarian neoplasm	Tubulin stabiliser	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	triple-negative breast cancer	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	peritoneum cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	adult acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Suspended	ClinicalTrials
VINCRISTINE	Small molecule	classic Hodgkin lymphoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	follicular lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	metastatic malignant neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
VINBLASTINE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	carcinoma	Tubulin inhibitor	4.0	-	DailyMed
VINORELBINE	Small molecule	lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
MIRVETUXIMAB SORAVTANSINE	Antibody	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINORELBINE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
T-900607	Small molecule	ovarian neoplasm	Tubulin disrupting agent	2.0	Unknown status	ClinicalTrials
ERIBULIN	Small molecule	triple-negative breast cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	ovarian mucinous adenocarcinoma	Tubulin stabiliser	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	bladder transitional cell carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	Desmoid-type fibromatosis	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	salivary gland carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	peritoneum cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
ERIBULIN	Small molecule	cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	endometrial cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	primary peritoneal carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	mixed phenotype acute leukemia	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm of esophagus	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	Burkitts lymphoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	diffuse large B-cell lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	renal cell carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	sarcoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
PLINABULIN	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
VINBLASTINE	Small molecule	stricture	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	metastasis	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	cervical squamous cell carcinoma	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
VINCRISTINE	Small molecule	Langerhans Cell Histiocytosis	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINBLASTINE	Small molecule	skin cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	familial Mediterranean fever	Tubulin inhibitor	4.0	Completed	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	breast carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	neoplasm	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	melanoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
ERIBULIN	Small molecule	breast neoplasm	Tubulin inhibitor	4.0	Completed	ClinicalTrials
PATUPILONE	Small molecule	breast neoplasm	Tubulin stabiliser	2.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	gout	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	laryngeal squamous cell carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	oropharynx cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	neutropenia	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINORELBINE	Small molecule	cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	0.5	Completed	ClinicalTrials
VINCRISTINE	Small molecule	retinoblastoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	tufted angioma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	lung neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
IXABEPILONE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	cholangiocarcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	endometrium adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ARX-788	Unknown	triple-negative breast cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
FOSBRETABULIN DISODIUM	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	gastrointestinal disease	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	uterine leiomyosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	gastric cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	fungal infectious disease	Tubulin inhibitor	4.0	-	DailyMed
PACLITAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	breast cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	breast cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	breast cancer	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	endometrial cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	high grade B-cell lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	HIV-1 infection	Tubulin inhibitor	3.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	Hodgkins lymphoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
IXABEPILONE	Small molecule	breast carcinoma	Tubulin inhibitor	4.0	-	FDA
BRENTUXIMAB VEDOTIN	Antibody	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	lymphoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
ERIBULIN	Small molecule	renal cell carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	sarcoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	cervical adenocarcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
ERIBULIN	Small molecule	breast cancer	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	lung cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	classic Hodgkin lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	endometrial cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	Ewing sarcoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	breast carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	diffuse scleroderma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	lung adenocarcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	lymphoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	mesothelioma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	small cell lung carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	ovarian carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	inflammatory breast carcinoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	oropharynx cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	adult B acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	atypical teratoid rhabdoid tumor	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	gastric cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	urinary bladder carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	breast cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	0.5	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Suspended	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINBLASTINE	Small molecule	extragonadal germ cell tumor	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PINATUZUMAB VEDOTIN	Antibody	follicular lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	neoplasm of mature B-cells	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINBLASTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	endometrioid carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	leukemia	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	neoplasm	Tubulin inhibitor	0.5	Recruiting	ClinicalTrials
GLEMBATUMUMAB VEDOTIN	Antibody	osteosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	sarcoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
GLEMBATUMUMAB VEDOTIN	Antibody	squamous cell lung carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	breast neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
VINCRISTINE	Small molecule	Mantle cell lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	adult acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
CABAZITAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
CABAZITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Enrolling by invitation	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PATUPILONE	Small molecule	prostate cancer	Tubulin stabiliser	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	lung cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
VINCRISTINE	Small molecule	follicular lymphoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	renal pelvis/ureter urothelial carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	low grade glioma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PATUPILONE	Small molecule	hepatocellular carcinoma	Tubulin stabiliser	2.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	diffuse large B-cell lymphoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINORELBINE	Small molecule	neuroblastoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	triple-negative breast cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Thymoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
IXABEPILONE	Small molecule	soft tissue sarcoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	peritoneum cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINORELBINE	Small molecule	rhabdomyosarcoma with mixed embryonal and alveolar features	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	childhood germ cell tumor	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	urethra cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	salivary gland cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
IXABEPILONE	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	breast carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	diffuse large B-cell lymphoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	lung adenocarcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	ovarian carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	multiple myeloma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
AZINTUXIZUMAB VEDOTIN	Antibody	multiple myeloma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic adenocarcinoma	Tubulin inhibitor	0.5	Completed	ClinicalTrials
DOCETAXEL	Small molecule	penile cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	uterine cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	adult acute lymphoblastic leukemia	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
VINORELBINE	Small molecule	breast cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	lung cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	lung cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	gastrointestinal stromal tumor	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	lung neoplasm	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
COLCHICINE	Small molecule	atrial fibrillation	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	lung adenocarcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINORELBINE	Small molecule	sarcoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	HIV infection	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	multiple myeloma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINFLUNINE	Small molecule	urogenital neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	non-Hodgkins lymphoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	bladder transitional cell carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	Malignant Ovarian Brenner Tumor	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
APRUTUMAB IXADOTIN	Antibody	cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	Hodgkins lymphoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	acute myeloid leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	ovarian carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
CABAZITAXEL	Small molecule	dedifferentiated liposarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	urogenital neoplasm	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	ovarian neoplasm	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	laryngeal squamous cell carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	peritoneal neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	urinary bladder cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	allergic disease	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	breast cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	lung cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	endometrial cancer	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
LAROTAXEL	Small molecule	bladder tumor	Tubulin stabiliser	3.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	mesothelioma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	sarcoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
BELANTAMAB MAFODOTIN	Antibody	multiple myeloma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
ASG-5ME	Antibody	prostate carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic ductal adenocarcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	medulloblastoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	4.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
FOSBRETABULIN DISODIUM	Small molecule	wet macular degeneration	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	nodular sclerosis Hodgkin lymphoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINORELBINE	Small molecule	triple-negative breast cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINBLASTINE	Small molecule	fungal infectious disease	Tubulin inhibitor	4.0	-	DailyMed
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
MIRVETUXIMAB SORAVTANSINE	Antibody	ovarian cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
CABAZITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	4.0	-	DailyMed
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Suspended	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	hepatocellular carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	alveolar rhabdomyosarcoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	germ cell tumor	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINBLASTINE	Small molecule	melanoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	small cell carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Central Nervous System Neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Central Nervous System Neoplasm	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	mesenchymoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Merkel cell skin cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	gastric cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	high grade B-cell lymphoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	breast adenocarcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
SAGOPILONE	Small molecule	glioblastoma multiforme	Tubulin stabiliser	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	lymphoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	neoplasm	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	sarcoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
IXABEPILONE	Small molecule	male breast carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	gliosarcoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	cutaneous melanoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	mesothelioma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	neuroblastoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	multiple myeloma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	stomach neoplasm	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic adenocarcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	cervical squamous cell carcinoma	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	renovascular hypertension	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	gastric cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	gastroesophageal junction adenocarcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	classic Hodgkin lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	carcinoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
VINBLASTINE	Small molecule	lymphoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	neuroblastoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	cervical carcinoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	cervical carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	4.0	Not yet recruiting	ClinicalTrials
VINCRISTINE	Small molecule	brain neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	pancreatic neoplasm	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
MILATAXEL	Small molecule	colonic neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Malignant Ovarian Brenner Tumor	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	childhood T acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	mucosal melanoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINORELBINE	Small molecule	vaginal cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
VINBLASTINE	Small molecule	urethra cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	4.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	Hereditary breast and ovarian cancer syndrome	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	Ewing sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	oral squamous cell carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	cutaneous melanoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Kaposi's sarcoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	leiomyosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	melanoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	medulloblastoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PATUPILONE	Small molecule	peritoneal neoplasm	Tubulin stabiliser	3.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	adult T acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	lymphoblastic lymphoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	gastric cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	neoplasm of mature B-cells	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	adenocarcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	mesothelioma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINORELBINE	Small molecule	malignant pleural mesothelioma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	ovarian carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	uterine sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	anaplastic large cell lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	urogenital neoplasm	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINORELBINE	Small molecule	upper aerodigestive tract neoplasm	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
VINCRISTINE	Small molecule	nodular sclerosis Hodgkin lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	rhabdomyosarcoma with mixed embryonal and alveolar features	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	gastroesophageal junction adenocarcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	human papillomavirus-related squamous cell carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	neoplasm	Tubulin inhibitor	0.5	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
ABT-751	Small molecule	renal cell carcinoma	Tubulin beta inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	sarcoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	AIDS	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
VINCRISTINE	Small molecule	lymphoblastic lymphoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	4.0	-	DailyMed
DOLASTATIN-10	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	lung cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	classic Hodgkin lymphoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	leukemia	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	lymphoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
COLCHICINE	Small molecule	myocardial infarction	Tubulin inhibitor	4.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	neoplasm	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	metastatic melanoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Suspended	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	ovarian neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	pericarditis	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Endometrial Undifferentiated Carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	colorectal carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	salivary gland squamous cell carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	lymphoblastic lymphoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
VINCRISTINE	Small molecule	undifferentiated high grade pleomorphic sarcoma of bone	Tubulin inhibitor	3.0	Completed	ClinicalTrials
ENFORTUMAB VEDOTIN	Antibody	cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
CABAZITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	malignant epithelial tumor of ovary	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	low grade glioma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	nasal cavity and paranasal sinus squamous cell carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	breast adenocarcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	sarcoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	ovarian carcinoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
ABT-751	Small molecule	non-small cell lung carcinoma	Tubulin beta inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	inflammatory breast carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	soft tissue sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	Richter syndrome	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
ERIBULIN	Small molecule	cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	breast cancer	Tubulin inhibitor	4.0	Recruiting	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINORELBINE	Small molecule	breast cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	lung cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	invasive breast ductal carcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	lung adenocarcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINORELBINE	Small molecule	mesothelioma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	neoplasm	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	ovarian carcinoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
BELANTAMAB MAFODOTIN	Antibody	multiple myeloma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	metastatic melanoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	rhabdomyosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	uterine neoplasm	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	metastasis	Tubulin inhibitor	2.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	colorectal carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
IXABEPILONE	Small molecule	peritoneum cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	ovarian cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINORELBINE	Small molecule	lung cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	low grade glioma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	Hodgkins lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
AGS-16C3F	Unknown	clear cell renal carcinoma	Tubulin disrupting agent	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	lung adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	lymphoid neoplasm	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	metastatic melanoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
IXABEPILONE	Small molecule	anaplastic large cell lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	non-small cell lung carcinoma	Tubulin stabiliser	2.0	Completed	ClinicalTrials
VERUBULIN	Small molecule	brain neoplasm	Tubulin disrupting agent	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	stomach neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	chronic hepatitis C virus infection	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	metastasis	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic adenocarcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	colorectal carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	endometrial adenosquamous carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	adult acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINORELBINE	Small molecule	metastatic malignant neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	metastatic malignant neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	Ewing sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	acute myeloid leukemia	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	leukemia	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	neuroblastoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
AGS-16C3F	Unknown	renal cell carcinoma	Tubulin disrupting agent	2.0	Completed	ClinicalTrials
BELANTAMAB MAFODOTIN	Antibody	multiple myeloma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	4.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	kidney neoplasm	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
SAGOPILONE	Small molecule	Central Nervous System Neoplasm	Tubulin stabiliser	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	Central Nervous System Neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
GLEMBATUMUMAB VEDOTIN	Antibody	Uveal Melanoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	colorectal carcinoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	urinary bladder cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	biliary tract cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	pleomorphic rhabdomyosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ANG1005	Protein	malignant glioma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
VINBLASTINE	Small molecule	neoplasm	Tubulin inhibitor	4.0	-	ATC
PACLITAXEL	Small molecule	small cell lung carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	medulloblastoma	Tubulin inhibitor	0.5	Terminated	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	anaplastic large cell lymphoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	brain neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	childhood acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	gastric cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	peritoneum cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ENFORTUMAB VEDOTIN	Antibody	cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
ERIBULIN	Small molecule	breast carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	melanoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	multiple myeloma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	rhabdomyosarcoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINBLASTINE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	4.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	childhood acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	peritoneum cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
T-900607	Small molecule	liver cancer	Tubulin disrupting agent	2.0	Completed	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
SAGOPILONE	Small molecule	prostate cancer	Tubulin stabiliser	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	cholangiocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	triple-negative breast cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	ovarian clear cell adenocarcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	lymphoblastic lymphoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	Richter syndrome	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	adult acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	ovarian cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	extragonadal germ cell tumor	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	adult T-cell leukemia/lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	mixed phenotype acute leukemia	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	chronic lymphocytic leukemia	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	sarcoma	Tubulin inhibitor	0.5	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	cervical adenocarcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	ovarian neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	glioma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	Central Nervous System Neoplasm	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	Mantle cell lymphoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	urinary bladder cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	anus cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	peritoneum cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	endometrial cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
COLCHICINE	Small molecule	familial Mediterranean fever	Tubulin inhibitor	4.0	-	DailyMed
DAVUNETIDE	Protein	progressive supranuclear palsy	Tubulin stabiliser	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	mixed phenotype acute leukemia	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINBLASTINE	Small molecule	lymphoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	lymphoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	lymphoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
CABAZITAXEL	Small molecule	prostate carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	esophageal carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
COLCHICINE	Small molecule	heart failure	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Coronary Restenosis	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	inflammatory breast carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	peritoneum cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	liver cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	breast cancer	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
EPOTHILONE D	Small molecule	breast cancer	Tubulin stabiliser	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	endometrial cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	hepatocellular carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	ovarian carcinoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	ovarian carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	prostate carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
COLCHICINE	Small molecule	chronic kidney disease	Tubulin inhibitor	4.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	ovarian neoplasm	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	upper aerodigestive tract neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	cervical squamous cell carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	soft tissue sarcoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	breast cancer	Tubulin inhibitor	4.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	breast cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	follicular lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	neoplasm of mature B-cells	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
IXABEPILONE	Small molecule	Burkitts lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	ischemia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	neoplasm	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic ductal adenocarcinoma	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	ovarian serous adenocarcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	uterine neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	rectum cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	1.0	Suspended	ClinicalTrials
PACLITAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
ENFORTUMAB VEDOTIN	Antibody	cancer	Tubulin inhibitor	2.0	Enrolling by invitation	ClinicalTrials
VINORELBINE	Small molecule	breast cancer	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	retinoblastoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
SOBLIDOTIN	Small molecule	lung cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	cutaneous melanoma	Tubulin inhibitor	2.0	Suspended	ClinicalTrials
IXABEPILONE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	neoplasm	Tubulin inhibitor	4.0	-	ATC
COLCHICINE	Small molecule	coronary artery disease	Tubulin inhibitor	4.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	ovarian serous adenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	atherosclerosis	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	nodular sclerosis Hodgkin lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	glioma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
IXABEPILONE	Small molecule	laryngeal squamous cell carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Malignant Bone Neoplasm	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Ocular Melanoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	gastric cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	urinary bladder cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINFLUNINE	Small molecule	breast cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	breast cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	high grade B-cell lymphoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINORELBINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	T-cell acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
LEXIBULIN	Small molecule	glioblastoma multiforme	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	lung adenocarcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	lymphoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
ERIBULIN	Small molecule	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	severe acute respiratory syndrome	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	ovarian carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	multiple myeloma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic ductal adenocarcinoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	stomach neoplasm	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	HER2 Positive Breast Carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	Langerhans Cell Histiocytosis	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	Abnormality of blood and blood-forming tissues	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
VINCRISTINE	Small molecule	kidney cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	biliary tract cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	salivary gland cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	4.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	lung cancer	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
COLCHICINE	Small molecule	familial Mediterranean fever	Tubulin inhibitor	1.0	Completed	ClinicalTrials
CABAZITAXEL	Small molecule	metastatic prostate cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	lymphoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
CABAZITAXEL	Small molecule	neoplasm	Tubulin inhibitor	4.0	-	ATC
MILATAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	male breast carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
COLCHICINE	Small molecule	primary biliary cirrhosis	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	uterine leiomyosarcoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	kidney cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	4.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Enrolling by invitation	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	neoplasm of mature B-cells	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	0.5	Recruiting	ClinicalTrials
ERIBULIN	Small molecule	lymphoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	neuroblastoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	osteosarcoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	renal cell carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	bladder transitional cell carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	stricture	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	Hepatoblastoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINFLUNINE	Small molecule	Transitional Cell Carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	Mantle cell lymphoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	urinary bladder cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	cervical cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	ovarian clear cell cystadenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	breast ductal carcinoma in situ	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	leukemia	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	malignant pleural mesothelioma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	metastatic melanoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	4.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	bladder transitional cell carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	pancreatic adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	Malignant Ovarian Brenner Tumor	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	Thyroid Gland Undifferentiated (Anaplastic) Carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	Lymphoma, AIDS-Related	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	soft tissue sarcoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	childhood acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	kidney cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DAVUNETIDE	Protein	schizophrenia	Tubulin stabiliser	2.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	breast cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
CABAZITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	4.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	retinoblastoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	lung cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
CABAZITAXEL	Small molecule	metastatic prostate cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	breast adenocarcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINBLASTINE	Small molecule	lymphoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	4.0	-	ATC
DOCETAXEL	Small molecule	prostate carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	esophageal carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	pancreatic neoplasm	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	stomach neoplasm	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	endometrial neoplasm	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
VINORELBINE	Small molecule	cervical cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	cervical cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
ARX-788	Unknown	breast cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Suspended	ClinicalTrials
PACLITAXEL	Small molecule	adenosquamous lung carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PLOCABULIN	Small molecule	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	neoplasm	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	cervical carcinoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	Cutaneous T-cell lymphoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	peripheral vascular disease	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Central Nervous System Neoplasm	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	Fallopian Tube Serous Adenocarcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	gastric cancer	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	urinary bladder cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	peritoneum cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	cervical cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	retinoblastoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	extragonadal germ cell tumor	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOLASTATIN-10	Small molecule	malignant tumor of extrahepatic bile duct	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	B-cell acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	breast carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	leukemia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	neuroblastoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL DOCOSAHEXAENOIC ACID	Small molecule	metastatic melanoma	Tubulin stabiliser	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	rhabdomyosarcoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PATUPILONE	Small molecule	non-small cell lung carcinoma	Tubulin stabiliser	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	male reproductive organ cancer	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
COLCHICINE	Small molecule	acute myocardial infarction	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	ovarian clear cell adenocarcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	inflammatory breast carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	mesenchymoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Merkel cell skin cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	anal carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast cancer	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
IXABEPILONE	Small molecule	primary peritoneal carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	gastric carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	myelodysplastic syndrome	Tubulin inhibitor	1.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	leukemia	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	lung adenocarcinoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PLINABULIN	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	stomach neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	acute coronary syndrome	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	male breast carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
CABAZITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	follicular lymphoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	high grade B-cell lymphoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINBLASTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	glioblastoma multiforme	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	lung adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	uterine sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	rhabdomyosarcoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Suspended	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	salivary gland neoplasm	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	urogenital neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	chronic kidney disease	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
FOSBRETABULIN DISODIUM	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	urothelial carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	ovarian serous cystadenocarcinoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	Ovarian Transitional Cell Carcinoma	Tubulin stabiliser	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	gastric cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
BELANTAMAB MAFODOTIN	Antibody	AL amyloidosis	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	Hodgkins lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	alveolar rhabdomyosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	breast carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	lymphoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	bladder transitional cell carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
COLCHICINE	Small molecule	Non-ST Elevation Myocardial Infarction	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	metastasis	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	cervical squamous cell carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	cervical cancer	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
VINCRISTINE	Small molecule	adult acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
CABAZITAXEL	Small molecule	urinary bladder carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
ENFORTUMAB VEDOTIN	Antibody	cancer	Tubulin inhibitor	4.0	-	DailyMed
ERIBULIN	Small molecule	breast cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	4.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
CABAZITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
CABAZITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	metastatic malignant neoplasm	Tubulin inhibitor	0.5	Active, not recruiting	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	Hodgkins lymphoma	Tubulin inhibitor	4.0	-	DailyMed
VINCRISTINE SULFATE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
VINORELBINE	Small molecule	lung adenocarcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	sarcoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	small cell lung carcinoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	anaplastic large cell lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	anaplastic large cell lymphoma	Tubulin inhibitor	4.0	-	DailyMed
ERIBULIN MESYLATE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	nodular sclerosis Hodgkin lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Mantle cell lymphoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	intrahepatic cholangiocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	intrahepatic cholangiocarcinoma	Tubulin inhibitor	2.0	Suspended	ClinicalTrials
DOCETAXEL	Small molecule	Fatigue	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	lymphoblastic lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	urinary bladder cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINORELBINE	Small molecule	fallopian tube cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PATUPILONE	Small molecule	ovarian cancer	Tubulin stabiliser	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	B-cell acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	angioimmunoblastic T-cell lymphoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	lymphoma	Tubulin inhibitor	4.0	-	DailyMed
DOCETAXEL	Small molecule	sarcoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	0.5	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic neoplasm	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	endometrial neoplasm	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	upper aerodigestive tract neoplasm	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	non-Hodgkins lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	ovarian serous cystadenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Central Nervous System Neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	salivary gland squamous cell carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	urinary bladder cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	cervical cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	primary brain neoplasm	Tubulin inhibitor	0.5	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	T-lymphoblastic lymphoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	metastatic prostate cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	adenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	angioimmunoblastic T-cell lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	Burkitts lymphoma	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINBLASTINE	Small molecule	lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	osteosarcoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
VINCRISTINE	Small molecule	anaplastic large cell lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	laryngeal neoplasm	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PATUPILONE	Small molecule	carcinoid tumor	Tubulin stabiliser	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	bladder transitional cell carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	bladder transitional cell carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	gastrointestinal disease	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINFLUNINE	Small molecule	urinary bladder cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	peritoneum cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	peritoneum cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	cervical cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	malignant epithelial tumor of ovary	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PINATUZUMAB VEDOTIN	Antibody	chronic lymphocytic leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	Hodgkins lymphoma	Tubulin inhibitor	4.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast adenocarcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	breast carcinoma	Tubulin inhibitor	4.0	-	DailyMed
ERIBULIN	Small molecule	breast carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	mesothelioma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	lymphoid neoplasm	Tubulin inhibitor	4.0	-	DailyMed
VINCRISTINE	Small molecule	rhabdomyosarcoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
ERIBULIN	Small molecule	angiosarcoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
ERIBULIN	Small molecule	urothelial carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	metastasis	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Mantle cell lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	urinary bladder cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	urinary bladder cancer	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
TISOTUMAB VEDOTIN	Antibody	cervical cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	lung cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	hematopoietic and lymphoid cell neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINBLASTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	adenosquamous lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	melanoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	metastatic melanoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	large cell lung carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	endometrium adenocarcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINORELBINE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	soft tissue sarcoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	peritoneum cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	cervical cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	Wilms tumor	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Suspended	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm of esophagus	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	oropharyngeal carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	gastric carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
VINORELBINE	Small molecule	embryonal rhabdomyosarcoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINORELBINE	Small molecule	lung adenocarcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINORELBINE	Small molecule	mesothelioma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	melanoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	esophageal carcinoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINFLUNINE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	0.5	Recruiting	ClinicalTrials
SAGOPILONE	Small molecule	breast neoplasm	Tubulin stabiliser	2.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	osteoarthritis, knee	Tubulin inhibitor	2.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	acute coronary syndrome	Tubulin inhibitor	4.0	Recruiting	ClinicalTrials
ENFORTUMAB VEDOTIN	Antibody	urothelial carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	oropharynx cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
ERIBULIN	Small molecule	cervical cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	ovarian cancer	Tubulin stabiliser	1.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	lung cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	follicular lymphoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	renal pelvis/ureter urothelial carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	sarcoma	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	metastatic melanoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	hypopharyngeal carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
LIFASTUZUMAB VEDOTIN	Antibody	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	pancreatic adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	gastric cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	cervical cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	cancer	Tubulin inhibitor	4.0	Completed	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	breast cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal adenocarcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	melanoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	cervical carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
BELANTAMAB MAFODOTIN	Antibody	multiple myeloma	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	prostate carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	non-small cell lung carcinoma	Tubulin stabiliser	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	4.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	stomach neoplasm	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
FOSBRETABULIN	Small molecule	wet macular degeneration	Tubulin inhibitor	1.0	Completed	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	metastasis	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINORELBINE	Small molecule	cervical squamous cell carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	mycosis fungoides	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	Mantle cell lymphoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	soft tissue sarcoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	lymphoblastic lymphoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	urinary bladder cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Richter syndrome	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	kidney cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	adult acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
IXABEPILONE	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	carcinoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	ganglioneuroblastoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
SOBLIDOTIN	Small molecule	neoplasm	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	osteosarcoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
AZINTUXIZUMAB VEDOTIN	Antibody	multiple myeloma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic ductal adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	pain	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	metastasis	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINORELBINE	Small molecule	lung cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	familial Mediterranean fever	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	Burkitts lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	carcinoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	lung adenocarcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	neoplasm	Tubulin inhibitor	4.0	-	ATC
PACLITAXEL	Small molecule	neoplasm	Tubulin inhibitor	4.0	-	ATC
DOCETAXEL	Small molecule	melanoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	0.5	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	stomach neoplasm	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
IXABEPILONE	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	Desmoid-type fibromatosis	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	Central Nervous System Neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	cervical cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	cervical cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	breast cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
ENFORTUMAB VEDOTIN	Antibody	prostate cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	pleomorphic rhabdomyosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	ovarian sex cord-stromal tumor	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	nasal cavity and paranasal sinus carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINBLASTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	alveolar rhabdomyosarcoma	Tubulin inhibitor	3.0	Suspended	ClinicalTrials
PACLITAXEL	Small molecule	bladder tumor	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
TUSAMITAMAB RAVTANSINE	Antibody	neoplasm	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	melanoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	ovarian carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Ovarian Carcinosarcoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	0.5	Completed	ClinicalTrials
PACLITAXEL	Small molecule	metastatic malignant neoplasm	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	0.5	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Kaposi's sarcoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
CABAZITAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic ductal adenocarcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	hypopharyngeal carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	hypopharyngeal carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
IXABEPILONE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	brain neoplasm	Tubulin stabiliser	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINCRISTINE	Small molecule	childhood acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Suspended	ClinicalTrials
DOCETAXEL	Small molecule	urinary bladder cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	classic Hodgkin lymphoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
MIRVETUXIMAB SORAVTANSINE	Antibody	primary peritoneal carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	ganglioneuroblastoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	small cell lung carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINORELBINE	Small molecule	breast neoplasm	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	upper aerodigestive tract neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	viral pneumonia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Endometrial Clear Cell Adenocarcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	HER2 Positive Breast Carcinoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	metastatic colorectal cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	metastatic colorectal cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	colorectal carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	urinary bladder cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	vaginal cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	cervical cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINBLASTINE	Small molecule	urinary bladder carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	breast cancer	Tubulin stabiliser	2.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOLASTATIN-10	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	Hodgkins lymphoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
BELANTAMAB MAFODOTIN	Antibody	multiple myeloma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	hypopharyngeal carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	4.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	vascular disease	Tubulin inhibitor	2.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	non-Hodgkins lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	male breast carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	pericarditis	Tubulin inhibitor	4.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	urothelial carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	urothelial carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Ovarian Carcinosarcoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	soft tissue sarcoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	peritoneum cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	thyroid cancer	Tubulin inhibitor	0.5	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
ERIBULIN	Small molecule	breast cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
ERIBULIN	Small molecule	breast cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	classic Hodgkin lymphoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	enteropathy-associated T-cell lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	neoplasm of esophagus	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	neoplasm of mature B-cells	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PATUPILONE	Small molecule	glioblastoma multiforme	Tubulin stabiliser	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	lymphoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
COLCHICINE	Small molecule	myocardial infarction	Tubulin inhibitor	2.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	neoplasm	Tubulin inhibitor	4.0	-	ATC
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	cervical carcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	colorectal cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	verrucous carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	precursor T-cell lymphoblastic leukemia-lymphoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	urinary bladder carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
LADIRATUZUMAB VEDOTIN	Antibody	breast cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	lung cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	gastrointestinal stromal tumor	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	hemophagocytic syndrome	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	gestational trophoblastic neoplasm	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	lymphoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	lymphoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	neoplasm	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	small cell lung carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	male breast carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	Endometrial Serous Adenocarcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	inflammatory breast carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	metastatic colorectal cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	childhood T acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	urinary bladder cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	Richter syndrome	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal small cell neuroendocrine carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
ARX-788	Unknown	cancer	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
IXABEPILONE	Small molecule	breast cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINBLASTINE	Small molecule	lung cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	adult T-cell leukemia/lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	COVID-19	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	lymphoma	Tubulin inhibitor	4.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	renal cell carcinoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
DOLASTATIN-10	Small molecule	pancreatic carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	medulloblastoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	triple-negative breast cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic adenocarcinoma	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	Central Nervous System Neoplasm	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	Fallopian Tube Carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	Malignant Ovarian Mixed Epithelial Tumor	Tubulin inhibitor	3.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	mycosis fungoides	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
PLINABULIN	Small molecule	neutropenia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	cervical cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	0.5	Unknown status	ClinicalTrials
VINORELBINE	Small molecule	breast cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	systemic lupus erythematosus	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	lung cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
VINORELBINE	Small molecule	lung cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	endometrial cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	4.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	myelodysplastic syndrome	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	lung adenocarcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
IXABEPILONE	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	rhabdomyosarcoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	stomach neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	stomach neoplasm	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	lymphoid leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	bladder transitional cell carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Lymphoma, AIDS-Related	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	classic Hodgkin lymphoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	prostate adenocarcinoma	Tubulin stabiliser	2.0	Completed	ClinicalTrials
PATUPILONE	Small molecule	prostate adenocarcinoma	Tubulin stabiliser	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	multiple myeloma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	cervical adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	cervical adenocarcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	upper aerodigestive tract neoplasm	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	ovarian mucinous adenocarcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	primary peritoneal carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	post-transplant lymphoproliferative disease	Tubulin inhibitor	2.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	Hodgkins lymphoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	breast carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	lymphoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	neoplasm	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
OMBRABULIN	Small molecule	sarcoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	ovarian mucinous adenocarcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	Anorexia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	cervical cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
CABAZITAXEL	Small molecule	infiltrating bladder urothelial carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
CABAZITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	endometrial cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	malignant epithelial tumor of ovary	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	cervical intraepithelial neoplasia	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
VINCRISTINE	Small molecule	T-cell acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
OMBRABULIN	Small molecule	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	Endometrial Serous Adenocarcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	HER2 Positive Breast Carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Poorly Differentiated Thyroid Gland Carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	Primary Peritoneal Serous Adenocarcinoma	Tubulin stabiliser	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	intrahepatic cholangiocarcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	gastric cancer	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	peritoneum cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	undifferentiated high grade pleomorphic sarcoma of bone	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	4.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
ERIBULIN	Small molecule	primary peritoneal carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	Burkitts lymphoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	endometrioid carcinoma	Tubulin stabiliser	3.0	Active, not recruiting	ClinicalTrials
VINORELBINE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	urothelial carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	optic nerve glioblastoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Ovarian Germ Cell Tumor	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	Thymic Carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	inflammatory breast carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	breast carcinoma in situ	Tubulin inhibitor	1.0	Suspended	ClinicalTrials
VINFLUNINE	Small molecule	breast cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	4.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	adult T-cell leukemia/lymphoma	Tubulin inhibitor	4.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	neoplasm of mature B-cells	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PATUPILONE	Small molecule	neoplasm	Tubulin stabiliser	1.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	small cell lung carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
SAGOPILONE	Small molecule	melanoma	Tubulin stabiliser	2.0	Completed	ClinicalTrials
PLINABULIN	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
KOS-1584	Small molecule	non-small cell lung carcinoma	Tubulin stabiliser	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
ARX-788	Unknown	angiosarcoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	triple-negative breast cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	Hepatoblastoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	breast cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	hemophagocytic syndrome	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	hepatocellular carcinoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	metastatic prostate cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	endometrioid carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	neoplasm	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	neuroblastoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
CABAZITAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINBLASTINE	Small molecule	metastatic melanoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	ovarian serous adenocarcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	mouth neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	stomach neoplasm	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	ovarian mucinous adenocarcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Fallopian Tube Carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Suspended	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	high grade B-cell lymphoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
COLCHICINE	Small molecule	COVID-19	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
TISOTUMAB VEDOTIN	Antibody	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	anaplastic large cell lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
FOSBRETABULIN DISODIUM	Small molecule	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	4.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic ductal adenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	laryngeal neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
CABAZITAXEL	Small molecule	adrenal cortex carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Mantle cell lymphoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	breast cancer	Tubulin stabiliser	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	4.0	-	DailyMed
PACLITAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	hematopoietic and lymphoid cell neoplasm	Tubulin inhibitor	0.5	Recruiting	ClinicalTrials
PACLITAXEL DOCOSAHEXAENOIC ACID	Small molecule	hepatocellular carcinoma	Tubulin stabiliser	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	T-cell acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
VINCRISTINE	Small molecule	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	4.0	-	DailyMed
PACLITAXEL	Small molecule	cutaneous melanoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
CABAZITAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	multiple myeloma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
SOFITUZUMAB VEDOTIN	Antibody	pancreatic carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	esophageal carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	medulloblastoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	4.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	ovarian neoplasm	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	bladder transitional cell carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	adult acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	cancer	Tubulin inhibitor	1.0	Suspended	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	mixed neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PATUPILONE	Small molecule	malignant colon neoplasm	Tubulin stabiliser	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	rhabdomyosarcoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	laryngeal squamous cell carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	male reproductive organ cancer	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	gastroesophageal junction adenocarcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	acute T cell leukemia	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	lung cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	low grade glioma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Hereditary breast and ovarian cancer syndrome	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINCRISTINE	Small molecule	acute myeloid leukemia	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	leukemia	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	mesothelioma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINFLUNINE	Small molecule	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	multiple myeloma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	cervical adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	upper aerodigestive tract neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	primitive neuroectodermal tumor	Tubulin inhibitor	3.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	non-Hodgkins lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	cervical squamous cell carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Endometrial Mucinous Adenocarcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	peritoneal neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	adult B acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
FOSBRETABULIN	Small molecule	thyroid cancer	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	cervical cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	childhood germ cell tumor	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PATUPILONE	Small molecule	cancer	Tubulin stabiliser	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINBLASTINE	Small molecule	lung cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	neoplasm of mature B-cells	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
LORVOTUZUMAB MERTANSINE	Antibody	leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	lymphoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	sarcoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	small cell lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	upper aerodigestive tract neoplasm	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	urothelial carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	gastrointestinal disease	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	Thymic Carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	Richter syndrome	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	cancer	Tubulin inhibitor	1.0	Suspended	ClinicalTrials
MIRVETUXIMAB SORAVTANSINE	Antibody	breast cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	renal pelvis/ureter urothelial carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
COLCHICINE	Small molecule	COVID-19	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	osteosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	coronary artery disease	Tubulin inhibitor	4.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	4.0	-	DailyMed
PACLITAXEL	Small molecule	mouth neoplasm	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	upper aerodigestive tract neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	male breast carcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
INDUSATUMAB VEDOTIN	Antibody	pancreatic adenocarcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	Anorexia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	kidney cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	choroid plexus neoplasm	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINORELBINE	Small molecule	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	Burkitts lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	lymphoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
BELANTAMAB MAFODOTIN	Antibody	multiple myeloma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	upper aerodigestive tract neoplasm	Tubulin inhibitor	4.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	male breast carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Fallopian Tube Serous Adenocarcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	Sinonasal Undifferentiated Carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	soft tissue sarcoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	cervical cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	gastroesophageal junction adenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	breast cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
CABAZITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	high grade B-cell lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
CABAZITAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Kaposi's sarcoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	leukemia	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
ERIBULIN	Small molecule	sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	melanoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	uterine sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	angiosarcoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	urothelial carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Primary Peritoneal Serous Adenocarcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Lymphoma, AIDS-Related	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Mantle cell lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	urinary bladder cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
FOSBRETABULIN DISODIUM	Small molecule	cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINCRISTINE	Small molecule	kaposiform hemangioendothelioma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	gastric carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINBLASTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	4.0	Recruiting	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	germ cell tumor	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	lymphoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	neuroblastoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	cervical adenocarcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	hypopharyngeal carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	breast neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	fallopian tube cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	breast cancer	Tubulin inhibitor	4.0	-	DailyMed
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	4.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	hepatocellular carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINBLASTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	4.0	Active, not recruiting	ClinicalTrials
ERIBULIN	Small molecule	ovarian carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	ovarian neoplasm	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	endometrial neoplasm	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	soft tissue sarcoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	lung cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINORELBINE	Small molecule	endometrial cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	endometrial cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PINATUZUMAB VEDOTIN	Antibody	diffuse large B-cell lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	4.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	multiple myeloma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	4.0	-	DailyMed
DOCETAXEL	Small molecule	stomach neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	stomach neoplasm	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	Waldenstrom macroglobulinemia	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	childhood B acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	colorectal carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	salivary gland carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINBLASTINE	Small molecule	urinary bladder cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOLASTATIN-10	Small molecule	gallbladder cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	neoplasm of mature B-cells	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	Hodgkins lymphoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINCRISTINE	Small molecule	rhabdomyosarcoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
ERIBULIN	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Fallopian Tube Carcinosarcoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
MILATAXEL	Small molecule	rectum cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	peritoneal neoplasm	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	urinary bladder cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	urinary bladder cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
ERIBULIN	Small molecule	breast cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
FOSBRETABULIN	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	retinoblastoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
IXABEPILONE	Small molecule	lung cancer	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
VINCRISTINE	Small molecule	chronic lymphocytic leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	T-cell acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
ERIBULIN	Small molecule	breast adenocarcinoma	Tubulin inhibitor	3.0	Suspended	ClinicalTrials
DOCETAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	actinic keratosis	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	thyroid carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
TELISOTUZUMAB VEDOTIN	Antibody	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	stomach neoplasm	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	Uveal Melanoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	neuroendocrine carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
IXABEPILONE	Small molecule	cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
VINBLASTINE	Small molecule	renal pelvis/ureter urothelial carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	gastric carcinoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	rhabdomyosarcoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
ERIBULIN	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic adenocarcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic adenocarcinoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	Thyroid Gland Undifferentiated (Anaplastic) Carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	Cachexia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	peritoneum cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	T-lymphoblastic lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	chronic lymphocytic leukemia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	metastatic prostate cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	alveolar rhabdomyosarcoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
MILATAXEL	Small molecule	mesothelioma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
RG-7841	Unknown	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	esophageal carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	ovarian serous adenocarcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	testicular neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	undifferentiated carcinoma	Tubulin stabiliser	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	myelosuppression	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINORELBINE	Small molecule	desmoplastic small round cell tumor	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	vaginal cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	urinary bladder carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PLINABULIN	Small molecule	cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	ovarian cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	lung cancer	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	lung cancer	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	diffuse large B-cell lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINBLASTINE	Small molecule	renal cell carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	rhabdomyosarcoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	stomach neoplasm	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	upper aerodigestive tract neoplasm	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	pharynx cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	adrenal cortex carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
CABAZITAXEL	Small molecule	penile neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	Mantle cell lymphoma	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	kidney cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINBLASTINE	Small molecule	cervical cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	cervical cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	T-lymphoblastic lymphoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
VINCRISTINE	Small molecule	alveolar rhabdomyosarcoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	lymphoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
IXABEPILONE	Small molecule	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Fallopian Tube Carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	endometrial carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	soft tissue sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	mucosal melanoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	laryngeal carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	liver cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
IXABEPILONE	Small molecule	breast cancer	Tubulin inhibitor	4.0	-	DailyMed
PACLITAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	lung cancer	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
VINORELBINE	Small molecule	lung neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	mesothelioma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	sarcoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINORELBINE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	childhood acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	brain cancer	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	endometrioid carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	prostate carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	anaplastic large cell lymphoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	0.5	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	cervical squamous cell carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
IXABEPILONE	Small molecule	breast cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PATUPILONE	Small molecule	breast cancer	Tubulin stabiliser	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	endometrial cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	follicular lymphoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	malignant colon neoplasm	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	metastatic malignant neoplasm	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	metastatic malignant neoplasm	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	4.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	4.0	Not yet recruiting	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	testicular neoplasm	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
COLCHICINE	Small molecule	acute coronary syndrome	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	Fallopian Tube Serous Adenocarcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	oropharynx cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	Fatigue	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	lymphoplasmacytic lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
ENFORTUMAB VEDOTIN	Antibody	urinary bladder cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	adult acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	ovarian clear cell cystadenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
LAROTAXEL	Small molecule	breast cancer	Tubulin stabiliser	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	gastrointestinal stromal tumor	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	squamous cell carcinoma of penis	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	follicular lymphoma	Tubulin inhibitor	2.0	Suspended	ClinicalTrials
DOCETAXEL	Small molecule	renal pelvis/ureter urothelial carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	myelodysplastic syndrome	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	adenosquamous lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	alveolar rhabdomyosarcoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	endometrioid carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	lymphoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	neoplasm	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	renal cell carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	large cell lung carcinoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	primitive neuroectodermal tumor	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	stricture	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
VINCRISTINE	Small molecule	blastic plasmacytoid dendritic cell neoplasm	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	toxicity	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	urinary bladder cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	urinary bladder cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	neuroendocrine carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINBLASTINE	Small molecule	skin cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	cancer	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
COLCHICINE	Small molecule	osteoarthritis	Tubulin inhibitor	4.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	allergic disease	Tubulin inhibitor	3.0	Completed	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	breast cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
ARX-788	Unknown	breast cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINORELBINE	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	adult T-cell leukemia/lymphoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	high grade B-cell lymphoma	Tubulin inhibitor	2.0	Suspended	ClinicalTrials
COLCHICINE	Small molecule	COVID-19	Tubulin inhibitor	0.5	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	Ewing sarcoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	astrocytoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	lymphoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	neoplasm	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	neoplasm	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	neuroblastoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	ovarian neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	peripheral arterial disease	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	ovarian clear cell adenocarcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Fallopian Tube Carcinosarcoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	breast cancer	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINORELBINE	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	malignant colon neoplasm	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Enrolling by invitation	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	leukemia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	neoplasm	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	endometrial neoplasm	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	upper aerodigestive tract neoplasm	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	triple-negative breast cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Endometrial Endometrioid Adenocarcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	Fallopian Tube Serous Adenocarcinoma	Tubulin stabiliser	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	HER2 Positive Breast Carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINBLASTINE	Small molecule	Langerhans Cell Histiocytosis	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Mantle cell lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	adult B acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	endometrial adenosquamous carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
ENFORTUMAB VEDOTIN	Antibody	cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PATUPILONE	Small molecule	cancer	Tubulin stabiliser	1.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	breast cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	follicular lymphoma	Tubulin inhibitor	4.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	hepatocellular carcinoma	Tubulin inhibitor	2.0	Suspended	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Enrolling by invitation	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	small cell lung carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	pancreatic neoplasm	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	lymphoid leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
T-900607	Small molecule	non-Hodgkins lymphoma	Tubulin disrupting agent	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	Chemotherapy-induced nausea and vomiting	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	urothelial carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	toxicity	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	Ovarian Transitional Cell Carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Primary Peritoneal Serous Adenocarcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
CABAZITAXEL	Small molecule	Transitional Cell Carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	colorectal carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
CABAZITAXEL	Small molecule	brain cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
MIRVETUXIMAB SORAVTANSINE	Antibody	fallopian tube cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	primary peritoneal carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
COLCHICINE	Small molecule	myocardial infarction	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	sarcoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
SAGOPILONE	Small molecule	small cell lung carcinoma	Tubulin stabiliser	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	melanoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	esophageal carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PATUPILONE	Small molecule	colonic neoplasm	Tubulin stabiliser	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	nodular sclerosis Hodgkin lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Central Nervous System Neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
MIRVETUXIMAB SORAVTANSINE	Antibody	Endometrial Clear Cell Adenocarcinoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	peritoneum cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINBLASTINE	Small molecule	urinary bladder carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
ERIBULIN	Small molecule	breast cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	retinoblastoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	classic Hodgkin lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	adenocarcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
LORVOTUZUMAB MERTANSINE	Antibody	synovial sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	4.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
VINCRISTINE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	lymphoblastic lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	urinary bladder carcinoma	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	0.5	Completed	ClinicalTrials
VINORELBINE	Small molecule	breast cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	primary peritoneal carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	anaplastic ependymoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	HIV-1 infection	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast adenocarcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Burkitts lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	hypertension	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	leukemia	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	lymphoma	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	lymphoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL DOCOSAHEXAENOIC ACID	Small molecule	non-small cell lung carcinoma	Tubulin stabiliser	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	ovarian neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	gout	Tubulin inhibitor	4.0	-	DailyMed,ATC
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	soft tissue sarcoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOLASTATIN-10	Small molecule	kidney cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
CABAZITAXEL	Small molecule	nongerminomatous germ cell tumor	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	metastatic malignant neoplasm	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	metastatic prostate cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINBLASTINE	Small molecule	cutaneous melanoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal adenocarcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	small cell lung carcinoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
COLCHICINE	Small molecule	heart failure	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
COLCHICINE	Small molecule	aphthous ulcer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	triple-negative breast cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Fallopian Tube Carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	soft tissue sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	neutropenia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	cervical cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	endometrial cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	follicular lymphoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	post-transplant lymphoproliferative disease	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	T-lymphoblastic lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
COLCHICINE	Small molecule	atrial fibrillation	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	4.0	-	ATC
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	uterine neoplasm	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	uterine neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	upper aerodigestive tract neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	urothelial carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	Ovarian Carcinosarcoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	mycosis fungoides	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	endometrial carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	adult acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	graft versus host disease	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	carcinoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
COLCHICINE	Small molecule	cardiovascular disease	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
CABAZITAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
COLCHICINE	Small molecule	severe acute respiratory syndrome	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	4.0	-	DailyMed
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	urogenital neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	bladder transitional cell carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	sex cord-stromal tumor	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Fallopian Tube Carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	Lymphoma, AIDS-Related	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	ovarian mucinous cystadenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	urinary bladder cancer	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
ERIBULIN	Small molecule	cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINORELBINE	Small molecule	breast cancer	Tubulin inhibitor	0.5	Completed	ClinicalTrials
PACLITAXEL	Small molecule	endometrial cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	B-cell acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	chronic lymphocytic leukemia	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	breast carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	lung adenocarcinoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
SAGOPILONE	Small molecule	neoplasm	Tubulin stabiliser	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	multiple myeloma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
COLCHICINE	Small molecule	coronary artery disease	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	Malignant Ovarian Brenner Tumor	Tubulin stabiliser	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	colorectal carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	ovarian mucinous cystadenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
TISOTUMAB VEDOTIN	Antibody	cervical cancer	Tubulin inhibitor	4.0	-	FDA
COLCHICINE	Small molecule	asthma	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
TELISOTUZUMAB VEDOTIN	Antibody	cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINORELBINE	Small molecule	cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
IXABEPILONE	Small molecule	prostate cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
ERIBULIN	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
ENFORTUMAB VEDOTIN	Antibody	renal pelvis/ureter urothelial carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	metastatic prostate cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
ERIBULIN	Small molecule	breast carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
ERIBULIN	Small molecule	osteosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	multiple myeloma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	esophageal carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	peritoneum cancer	Tubulin stabiliser	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	peritoneum cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
CROLIBULIN	Small molecule	cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	gallbladder cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	breast cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	classic Hodgkin lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	primary peritoneal carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	chronic lymphocytic leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	gastric carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	neoplasm	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
LORVOTUZUMAB MERTANSINE	Antibody	small cell lung carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	multiple myeloma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	brain neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	endometrial neoplasm	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	colorectal carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
ABT-751	Small molecule	childhood acute lymphoblastic leukemia	Tubulin beta inhibitor	1.0	Terminated	ClinicalTrials
COLCHICINE	Small molecule	pericardial effusion	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	biliary tract cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	acute myeloid leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOLASTATIN-10	Small molecule	lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	cervical adenocarcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
ABT-751	Small molecule	lymphoid neoplasm	Tubulin beta inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	large cell lung carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	upper aerodigestive tract neoplasm	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
VINFLUNINE	Small molecule	bladder transitional cell carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	vasculitis	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	toxicity	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	Ovarian Transitional Cell Carcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	peritoneal neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	urinary bladder cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	kidney cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	4.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	0.5	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	gastric carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	gastric carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast adenocarcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	breast adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	lymphoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	melanoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	metastatic melanoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	ovarian mucinous adenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	childhood B acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	head and neck carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	endometrial cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
CABAZITAXEL	Small molecule	metastatic malignant neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	Hodgkins lymphoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	oral squamous cell carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	adenosquamous lung carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	diffuse large B-cell lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	ganglioneuroblastoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	lung adenocarcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic ductal adenocarcinoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
LORVOTUZUMAB MERTANSINE	Antibody	rhabdomyosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	primitive neuroectodermal tumor	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	HER2 Positive Breast Carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	small intestinal adenocarcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	urinary bladder carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	breast cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	mesothelioma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
ERIBULIN	Small molecule	neoplasm	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
IXABEPILONE	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	triple-negative breast cancer	Tubulin inhibitor	2.0	Suspended	ClinicalTrials
PACLITAXEL	Small molecule	peritoneal neoplasm	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	retinoblastoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	lung neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	nasal cavity and paranasal sinus squamous cell carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	COVID-19	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
VINCRISTINE	Small molecule	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	lymphoma	Tubulin inhibitor	3.0	Suspended	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	ovarian carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
VINCRISTINE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	breast ductal adenocarcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINBLASTINE	Small molecule	urothelial carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	urothelial carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	inflammatory breast carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Mantle cell lymphoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DAVUNETIDE	Protein	Cognitive impairment	Tubulin stabiliser	2.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	pericardial effusion	Tubulin inhibitor	4.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	neutropenia	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINORELBINE	Small molecule	kidney cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	urethra cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	breast cancer	Tubulin stabiliser	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	lung cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	primary peritoneal carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	follicular lymphoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINBLASTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
MIRVETUXIMAB SORAVTANSINE	Antibody	breast carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
TUSAMITAMAB RAVTANSINE	Antibody	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	triple-negative breast cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	Central Nervous System Neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Malignant Ovarian Brenner Tumor	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	colorectal carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	gastric cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	vulva cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	thyroid cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	endometrial cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	primary peritoneal carcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	follicular lymphoma	Tubulin inhibitor	4.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	renal pelvis/ureter urothelial carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	myocardial infarction	Tubulin inhibitor	4.0	Withdrawn	ClinicalTrials
IXABEPILONE	Small molecule	neoplasm	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
BELANTAMAB MAFODOTIN	Antibody	multiple myeloma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINORELBINE	Small molecule	large cell lung carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Coronary Restenosis	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
CABAZITAXEL	Small molecule	urothelial carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	Uterine Carcinosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	urethra cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
COLCHICINE	Small molecule	osteoarthritis	Tubulin inhibitor	4.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	lung cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	graft versus host disease	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	extragonadal germ cell tumor	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	adult T-cell leukemia/lymphoma	Tubulin inhibitor	4.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	neoplasm of mature B-cells	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	hepatocellular carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
IXABEPILONE	Small molecule	breast carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
CABAZITAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	sarcoma	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
VINCRISTINE	Small molecule	anaplastic large cell lymphoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	kidney neoplasm	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	ovarian neoplasm	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	upper aerodigestive tract neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Waldenstrom macroglobulinemia	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	lymphoblastic lymphoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
IXABEPILONE	Small molecule	breast cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	female reproductive system neoplasm	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	chronic lymphocytic leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
VINORELBINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	melanoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	esophageal carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	ovarian serous adenocarcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINORELBINE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
IXABEPILONE	Small molecule	uterine leiomyosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	mature T-cell and NK-cell non-Hodgkin lymphoma	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
FOSBRETABULIN	Small molecule	ovarian cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINORELBINE	Small molecule	lung cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	metastatic prostate cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
COLCHICINE	Small molecule	atrial fibrillation	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	esophageal adenocarcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	lymphoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	bladder transitional cell carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	autoimmune thrombocytopenic purpura	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINCRISTINE	Small molecule	follicular lymphoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	metastatic malignant neoplasm	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	oral squamous cell carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINBLASTINE	Small molecule	lymphoma	Tubulin inhibitor	4.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
SAGOPILONE	Small molecule	small cell lung carcinoma	Tubulin stabiliser	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	anaplastic large cell lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	triple-negative breast cancer	Tubulin inhibitor	2.0	Suspended	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	Transitional Cell Carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	intrahepatic cholangiocarcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	anal carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINFLUNINE	Small molecule	cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	endometrial cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	squamous cell carcinoma of penis	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	follicular lymphoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	adenosquamous lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINBLASTINE	Small molecule	cutaneous melanoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VERUBULIN	Small molecule	neoplasm	Tubulin disrupting agent	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	neuroblastoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINBLASTINE	Small molecule	melanoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	coronary artery disease	Tubulin inhibitor	4.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
ANG1005	Protein	brain neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	breast neoplasm	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	metastasis	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	urethra cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	endometrial cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	extragonadal germ cell tumor	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINBLASTINE	Small molecule	renal pelvis/ureter urothelial carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	gastric carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Burkitts lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
ERIBULIN	Small molecule	neoplasm	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINBLASTINE	Small molecule	sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic ductal adenocarcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	0.5	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	medulloblastoma	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	testicular carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	triple-negative breast cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
ENFORTUMAB VEDOTIN	Antibody	cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINORELBINE	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	laryngeal neoplasm	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
ENFORTUMAB VEDOTIN	Antibody	urothelial carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
FOSBRETABULIN TROMETHAMINE	Small molecule	neuroendocrine neoplasm	Tubulin disrupting agent	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	endometrial adenosquamous carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	thyroid cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	B-cell neoplasm	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINFLUNINE	Small molecule	lung cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	malignant epithelial tumor of ovary	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	lung neoplasm	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	breast carcinoma	Tubulin inhibitor	4.0	-	DailyMed
BRENTUXIMAB VEDOTIN	Antibody	anaplastic large cell lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	gout	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	male breast carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	ovarian clear cell adenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	Uterine Carcinosarcoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	inflammatory breast carcinoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	peritoneal neoplasm	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	cervical cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
SAGOPILONE	Small molecule	breast cancer	Tubulin stabiliser	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	high grade B-cell lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	T-lymphoblastic lymphoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	4.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	metastatic prostate cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	acute myeloid leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	0.5	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	melanoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	multiple myeloma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	biliary tract neoplasm	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
ERIBULIN	Small molecule	bladder transitional cell carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Hepatoblastoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	colorectal carcinoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	gastric cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PATUPILONE	Small molecule	fallopian tube cancer	Tubulin stabiliser	3.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	adult acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
COLCHICINE	Small molecule	amyotrophic lateral sclerosis	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINORELBINE	Small molecule	cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Wilms tumor	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	Wilms tumor	Tubulin inhibitor	4.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	prostate cancer	Tubulin stabiliser	2.0	Terminated	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	classic Hodgkin lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	metastatic malignant neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	neoplasm of mature B-cells	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
VINORELBINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	leukemia	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
INDIBULIN	Small molecule	neoplasm	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
VINORELBINE	Small molecule	neoplasm	Tubulin inhibitor	4.0	-	ATC
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	ovarian carcinoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
TUSAMITAMAB RAVTANSINE	Antibody	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	Fallopian Tube Carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
CABAZITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINORELBINE	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
ERIBULIN	Small molecule	breast carcinoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
VINCRISTINE	Small molecule	glioblastoma multiforme	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	brain neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Coronary Restenosis	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic adenocarcinoma	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
VINORELBINE	Small molecule	HER2 Positive Breast Carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Uveal Melanoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	metastatic colorectal cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	breast cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINBLASTINE	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	Castleman disease	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
VINCRISTINE	Small molecule	Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	neurofibromatosis type 1	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	mixed phenotype acute leukemia	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	metastatic prostate cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	T-cell acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	acute myeloid leukemia	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	carcinoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	melanoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	ovarian neoplasm	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	upper aerodigestive tract neoplasm	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic adenocarcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	Uterine Carcinosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	soft tissue sarcoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	neoplasm of mature B-cells	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	lung adenocarcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	lymphoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	hypopharyngeal carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
COLCHICINE	Small molecule	ST Elevation Myocardial Infarction	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic adenocarcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Fallopian Tube Carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	hemangioma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	salivary gland carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	peritoneum cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	cervical cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	adult acute lymphoblastic leukemia	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
IXABEPILONE	Small molecule	breast cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	4.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	primary peritoneal carcinoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	Hodgkins lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	invasive breast ductal carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Suspended	ClinicalTrials
VINORELBINE	Small molecule	alveolar rhabdomyosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	lymphoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	melanoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Central Nervous System Neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	endometrial endometrioid adenocarcinoma, variant with squamous differentiation	Tubulin inhibitor	3.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	soft tissue sarcoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	soft tissue sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINFLUNINE	Small molecule	gastric cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	gastric cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	peritoneum cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast cancer	Tubulin inhibitor	4.0	-	DailyMed
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	lung cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	endometrial cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	malignant epithelial tumor of ovary	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	oropharynx squamous cell carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
COLCHICINE	Small molecule	COVID-19	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINBLASTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	T-cell acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	T-cell acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	germ cell tumor	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	lung adenocarcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	lung adenocarcinoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
COLCHICINE	Small molecule	severe acute respiratory syndrome	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	4.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	gout	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	soft tissue sarcoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINBLASTINE	Small molecule	urinary bladder cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	mixed phenotype acute leukemia	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	metastatic malignant neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal adenocarcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	neoplasm	Tubulin stabiliser	3.0	-	ATC
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic ductal adenocarcinoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
IXABEPILONE	Small molecule	stomach neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	colorectal neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	upper aerodigestive tract neoplasm	Tubulin inhibitor	4.0	Completed	ClinicalTrials
CABAZITAXEL	Small molecule	testicular carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PLOCABULIN	Small molecule	colorectal cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	non-Hodgkins lymphoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	undifferentiated carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	pancreatic adenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	Mantle cell lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	urethra cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	breast carcinoma in situ	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	lung cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	primary peritoneal carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	metastatic prostate cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	alveolar rhabdomyosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
LEXIBULIN	Small molecule	multiple myeloma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
IXABEPILONE	Small molecule	anaplastic astrocytoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	laryngeal neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
ERIBULIN	Small molecule	male breast carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINFLUNINE	Small molecule	urothelial carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	urothelial carcinoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	ovarian serous cystadenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Endometrial Clear Cell Adenocarcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Abnormality of blood and blood-forming tissues	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	gastric cancer	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	urinary bladder cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	vulva cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
TISOTUMAB VEDOTIN	Antibody	peritoneum cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	kidney cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
VINCRISTINE	Small molecule	T-cell non-Hodgkin lymphoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINORELBINE	Small molecule	carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	small cell lung carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic adenocarcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	oropharynx cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
ERIBULIN	Small molecule	breast cancer	Tubulin inhibitor	4.0	Completed	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast carcinoma	Tubulin inhibitor	4.0	-	DailyMed
PACLITAXEL	Small molecule	bronchoalveolar adenocarcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
TELISOTUZUMAB VEDOTIN	Antibody	squamous cell lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	brain neoplasm	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	testicular carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	bladder transitional cell carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	autoimmune thrombocytopenic purpura	Tubulin inhibitor	4.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	peritoneal neoplasm	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	head and neck carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
COLCHICINE	Small molecule	COVID-19	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	neoplasm of mature B-cells	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	Ewing sarcoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	endometrioid carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	osteosarcoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	melanoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
BELANTAMAB MAFODOTIN	Antibody	multiple myeloma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	hypopharyngeal carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
VINORELBINE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	4.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	ovarian serous cystadenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic adenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	childhood T acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	kidney cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	cervical cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	primary peritoneal carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINBLASTINE	Small molecule	low grade glioma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	low grade glioma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Ewing sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	neoplasm	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	sarcoma	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	ovarian carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	0.5	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	urogenital neoplasm	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	angiosarcoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	peritoneal neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	cervical cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
FOSBRETABULIN TROMETHAMINE	Small molecule	ovarian cancer	Tubulin disrupting agent	2.0	Terminated	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	follicular lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	follicular lymphoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	metastatic malignant neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	high grade B-cell lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	breast adenocarcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	breast carcinoma	Tubulin inhibitor	1.0	Suspended	ClinicalTrials
PACLITAXEL	Small molecule	cutaneous melanoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	sarcoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	small cell lung carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	chronic myeloproliferative disorder	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	pancreatic neoplasm	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	biliary tract neoplasm	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
T-900607	Small molecule	gastric cancer	Tubulin disrupting agent	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	neutropenia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
COLCHICINE	Small molecule	COVID-19	Tubulin inhibitor	4.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	breast carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VERUBULIN	Small molecule	glioblastoma multiforme	Tubulin disrupting agent	2.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	osteosarcoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	sarcoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	small cell lung carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
IXABEPILONE	Small molecule	melanoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	metastatic melanoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINORELBINE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	4.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Hepatoblastoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Primary Peritoneal Serous Adenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	kidney cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	urinary bladder carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	malignant germ cell tumor of ovary	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	metastatic malignant neoplasm	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	neoplasm of mature B-cells	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
VINCRISTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	adenocarcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	embryonal rhabdomyosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	anaplastic astrocytoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	metastatic melanoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	triple-negative breast cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	non-Hodgkins lymphoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
IXABEPILONE	Small molecule	Uterine Carcinosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	gastric cancer	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	fallopian tube cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	urethra cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	lung cancer	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	endometrial cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	T-lymphoblastic lymphoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	ovarian carcinoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	peripheral arterial disease	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	peripheral primitive neuroectodermal tumor	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	malignant colon neoplasm	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	Hereditary breast and ovarian cancer syndrome	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	cutaneous melanoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
VINCRISTINE	Small molecule	embryonal rhabdomyosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
INDIBULIN	Small molecule	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
CABAZITAXEL	Small molecule	small cell lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PLINABULIN	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	peripheral arterial disease	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	Uterine Carcinosarcoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	urinary bladder cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	nasal cavity carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
EPOTHILONE D	Small molecule	prostate cancer	Tubulin stabiliser	2.0	Terminated	ClinicalTrials
VINBLASTINE	Small molecule	classic Hodgkin lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
MIRVETUXIMAB SORAVTANSINE	Antibody	endometrial cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINORELBINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
BELANTAMAB MAFODOTIN	Antibody	diffuse large B-cell lymphoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	endometrioid carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	large cell neuroendocrine carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINBLASTINE	Small molecule	lymphoma	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	lymphoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	multiple myeloma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic ductal adenocarcinoma	Tubulin inhibitor	4.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
TELISOTUZUMAB VEDOTIN	Antibody	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
COLCHICINE	Small molecule	rhegmatogenous retinal detachment	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	bladder transitional cell carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	Endometrial Clear Cell Adenocarcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	Fallopian Tube Carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
ABT-751	Small molecule	colorectal carcinoma	Tubulin beta inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	teratoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	cervical carcinosarcoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
IXABEPILONE	Small molecule	urinary bladder carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
INDUSATUMAB VEDOTIN	Antibody	cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
INDIBULIN	Small molecule	breast cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	classic Hodgkin lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	renal pelvis/ureter urothelial carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	metastatic malignant neoplasm	Tubulin inhibitor	0.5	Active, not recruiting	ClinicalTrials
CABAZITAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	4.0	-	DailyMed
BRENTUXIMAB VEDOTIN	Antibody	lymphoma	Tubulin inhibitor	4.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	rheumatoid arthritis	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	uterine neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	stomach neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	upper aerodigestive tract neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	laryngeal squamous cell carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	metastasis	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	inflammatory breast carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Lymphoma, AIDS-Related	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINORELBINE	Small molecule	urinary bladder cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
CABAZITAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	luminal B breast carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	neoplasm of mature B-cells	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	unspecified peripheral T-cell lymphoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	breast carcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINORELBINE	Small molecule	neoplasm	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
VINORELBINE	Small molecule	nodular sclerosis Hodgkin lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	male breast carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	toxicity	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
VINCRISTINE	Small molecule	childhood B acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	mature T-cell and NK-cell non-Hodgkin lymphoma	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	cervical cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	adult acute lymphoblastic leukemia	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	breast cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	breast cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	breast cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
T-900607	Small molecule	hepatocellular carcinoma	Tubulin disrupting agent	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	esophageal adenocarcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	gastric adenocarcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	lymphoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
VINCRISTINE	Small molecule	lymphoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
CABAZITAXEL	Small molecule	neoplasm	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	neoplasm	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	sarcoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal squamous cell carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	breast cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINORELBINE	Small molecule	breast cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
CABAZITAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	malignant tumor of neck	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	diffuse large B-cell lymphoma	Tubulin inhibitor	1.0	Not yet recruiting	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	diffuse scleroderma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	lymphoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	small cell lung carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	urogenital neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
FOSBRETABULIN	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	Central Nervous System Neoplasm	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	Ovarian Carcinosarcoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINBLASTINE	Small molecule	low grade glioma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	endometrioid carcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	sarcoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	squamous cell carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	squamous cell lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
BELANTAMAB MAFODOTIN	Antibody	multiple myeloma	Tubulin inhibitor	4.0	-	FDA,DailyMed
ERIBULIN	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	undifferentiated carcinoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	inflammatory breast carcinoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	peritoneal neoplasm	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	colorectal carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINFLUNINE	Small molecule	cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
ERIBULIN	Small molecule	breast cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	ovarian cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
DOCETAXEL	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	follicular lymphoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINBLASTINE	Small molecule	neurofibromatosis type 1	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	kidney Wilms tumor	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	neoplasm of mature B-cells	Tubulin inhibitor	3.0	Terminated	ClinicalTrials
VINORELBINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	alveolar rhabdomyosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	carcinoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
POLATUZUMAB VEDOTIN	Antibody	lymphoma	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
VINCRISTINE	Small molecule	lymphoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
BMS-275183	Small molecule	neoplasm	Tubulin stabiliser	1.0	Terminated	ClinicalTrials
PACLITAXEL	Small molecule	sarcoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	peripheral neuropathy	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	endometrial neoplasm	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	urothelial carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	mucosal melanoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	salivary gland cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ERIBULIN	Small molecule	breast cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
PACLITAXEL	Small molecule	breast cancer	Tubulin inhibitor	3.0	Suspended	ClinicalTrials
PACLITAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINORELBINE	Small molecule	ovarian cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	lung cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	neurofibromatosis type 1	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	chronic lymphocytic leukemia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINCRISTINE	Small molecule	acute lymphoblastic leukemia	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
PACLITAXEL	Small molecule	benign prostatic hyperplasia	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	lymphoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOCETAXEL	Small molecule	neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
EPOTHILONE D	Small molecule	neoplasm	Tubulin stabiliser	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	stomach neoplasm	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
CABAZITAXEL	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	small intestine cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	peritoneum cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
IXABEPILONE	Small molecule	breast cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast cancer	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	breast cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	retinoblastoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINBLASTINE	Small molecule	classic Hodgkin lymphoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINCRISTINE	Small molecule	mixed phenotype acute leukemia	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	head and neck squamous cell carcinoma	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
VINBLASTINE	Small molecule	Hodgkins lymphoma	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
PACLITAXEL	Small molecule	adenocarcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	lymphoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINCRISTINE	Small molecule	lymphoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	prostate adenocarcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
OMBRABULIN	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	breast neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
CABAZITAXEL	Small molecule	bladder transitional cell carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	stricture	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINORELBINE	Small molecule	male breast carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	Chemotherapy-induced nausea and vomiting	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	metastasis	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	Ovarian Carcinosarcoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Uveal Melanoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	Mantle cell lymphoma	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	cutaneous squamous cell carcinoma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINBLASTINE	Small molecule	kidney cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	ovarian clear cell cystadenocarcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
TRASTUZUMAB EMTANSINE	Antibody	cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
DOCETAXEL	Small molecule	cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
ERIBULIN MESYLATE	Small molecule	breast cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINORELBINE TARTRATE	Small molecule	alveolar rhabdomyosarcoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL	Small molecule	carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINCRISTINE SULFATE	Small molecule	lymphoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
VINORELBINE	Small molecule	mesothelioma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
IXABEPILONE	Small molecule	neoplasm	Tubulin inhibitor	4.0	-	ATC
PACLITAXEL	Small molecule	cervical carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	cervical adenocarcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	pancreatic carcinoma	Tubulin inhibitor	3.0	Unknown status	ClinicalTrials
ABT-751	Small molecule	non-small cell lung carcinoma	Tubulin beta inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	nasopharyngeal neoplasm	Tubulin inhibitor	3.0	Not yet recruiting	ClinicalTrials
ERIBULIN	Small molecule	triple-negative breast cancer	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
DOCETAXEL	Small molecule	oral cavity cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINORELBINE	Small molecule	non-Hodgkins lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL	Small molecule	urothelial carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
BRENTUXIMAB VEDOTIN	Antibody	mycosis fungoides	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOCETAXEL	Small molecule	breast cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
PRALUZATAMAB RAVTANSINE	Antibody	breast cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
PACLITAXEL	Small molecule	esophageal cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINBLASTINE SULFATE	Small molecule	classic Hodgkin lymphoma	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
IXABEPILONE	Small molecule	follicular lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials

Welcome to

RBP World!

Drugs target to TUBB4B

Targets details